000			01981 a2200541 4500
005			20250517121619.0
264		0	_c20170526
008			201705s 0 0 eng d
022			_a1474-5488
024	7		_a10.1016/S1470-2045(16)30498-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aLanger, Corey J
245	0	0	_aCarboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. _h[electronic resource]
260			_bThe Lancet. Oncology _cNov 2016
300			_a1497-1508 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCarboplatin _xadministration & dosage
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPemetrexed _xadministration & dosage
700	1		_aGadgeel, Shirish M
700	1		_aBorghaei, Hossein
700	1		_aPapadimitrakopoulou, Vassiliki A
700	1		_aPatnaik, Amita
700	1		_aPowell, Steven F
700	1		_aGentzler, Ryan D
700	1		_aMartins, Renato G
700	1		_aStevenson, James P
700	1		_aJalal, Shadia I
700	1		_aPanwalkar, Amit
700	1		_aYang, James Chih-Hsin
700	1		_aGubens, Matthew
700	1		_aSequist, Lecia V
700	1		_aAwad, Mark M
700	1		_aFiore, Joseph
700	1		_aGe, Yang
700	1		_aRaftopoulos, Harry
700	1		_aGandhi, Leena
773	0		_tThe Lancet. Oncology _gvol. 17 _gno. 11 _gp. 1497-1508
856	4	0	_uhttps://doi.org/10.1016/S1470-2045(16)30498-3 _zAvailable from publisher's website
999			_c26519559 _d26519559